Accuracy of histone H3 messenger RNA in situ hybridization for the assessment of cell proliferation in human tissues

Clinical Cancer Research

Volumn 3, Issue 5, 1997, Pages 669-673

  Kotelnikov, Valery ^a   Cass, Laura ^c   Coon, John S ^b   Spaulding, Dave ^c   Preisler, Harvey D ^a  

^a RUSH CANCER INSTITUTE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c AGILENT TECHNOLOGIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IDOXURIDINE; MESSENGER RNA;

ADULT; ARTICLE; CELL LABELING; CELL PROLIFERATION; CLINICAL ARTICLE; DNA DETERMINATION; HALOGENATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUTH TUMOR; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE;

BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; HEAD AND NECK NEOPLASMS; HISTONES; HUMANS; IDOXURIDINE; IN SITU HYBRIDIZATION; MITOTIC INDEX; MOUTH MUCOSA; MOUTH NEOPLASMS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; S PHASE;

EID: 0031009989     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Raza, A., Bokhari, J., Yousuf, N., Mehdi, A., Mazewski, C., Khan, S., Baker, V., and Lampkin, B. Cell cycle kinetic studies in human cancers. Development of three DNA-specific labels in three decades. Arch. Pathol. Lab. Med., 115: 873-879, 1991.
2. Camplejohn, R. S., and Macartney, J. C. Flow cytometry. In: P. A. Hall, Levison, D. A., and Wright, N. A. (eds.), Assessment of Cell Proliferation in Clinical Practice, pp. 93-111. London: Springer, 1992.
3. Bennett, M., Wilson, G., Dische, S., Saunders, M., Martindale, C., Robinson, B., O'Halloran, A., Leslie, M., and Laing, J. Tumor proliferation assessed by combined histological and flow cytometrical analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br. J. Cancer, 65: 870-878, 1992.
4. Begg, A. C. Critical appraisal of in situ cell kinetic measurements as response predictors in human tumors. Semin. Radiat. Oncol., 3: 144-151, 1993.
5. Kotelnikov, V. M., Coon, J., Haleem, A., Taylor, S., Hutchinson, J., Panje, W., Caldarelli, D., and Preisler, H. D. Cell kinetics of head and neck cancers. Clin. Cancer Res., 1: 527-537, 1995.
6. Coffino, P., Stimac, E., Groppi, V. E., and Bieber, D. Histone expression and the mammalian cell cycle. In: G. S. Stein. J. L. Stein, and W. F. Marzluff (eds.), Histone Genes. Structure, Organization, and Regulation, pp. 317-338. New York: John Wiley & Sons, Inc., 1984.
7. Lawrence J. B., Singer, R. H., Villnave, C. A., Stein, J. L., and Stein, G. S. Intracellular distribution of histone mRNAs in human fibroblasts studies by in situ hybridization. Proc. Natl. Acad. Sci USA, 85: 463-467, 1988.
8. Wong, D. T. W., Chou, M. Y., Chang, A. L. C., and Gallagher, G. T. Use of intracellular H3 messenger RNA as a marker to determine the proliferation pattern of normal and 7,12-dimethylbenz[a]anthracene-transformed hamster oral epithelium. Cancer Res., 50: 5107-5111, 1990.
9. Alison, M., Chaudry, Z., Baker, J., Lauder, I., and Pringle, H. Liver regeneration: a comparison of in situ hybridization for histone mRNA with bromodeoxyuridine labeling for the detection of S-phase cells. J. Histochem. Cytochem., 42: 1603-1608, 1994.
10. Konishi, H., Steinbach, G., Terry, N. H. A., Lee, J. J., Dubin, J. A., Glober, G. A., Fujita, K., Spaulding, D., Cass, L., and Hittelman, W. Histone H3 messenger RNA in situ hybridization correlates with in vivo bromodeoxyuridine labeling of S-phase cells in rat colonie epithelium. Cancer Res., 56: 434-437, 1996.
11. Gown, A. M., Jiang, J. J., Matles, H., Skelly, M., Goodpasture, T., Cass, L., Reshatoff, M., Spaulding, D., and Collera, M. D. Validation of the S-phase specificity of histone (H3) in situ hybridization in normal and malignant cells. J. Histochem. Cytochem., 44: 221-226, 1996.
12. Bosch, F. X., Udvarhelyi, N., Venter, E., Herold-Mende, C., Schuhmann, A., Maier, H., Weidauer, H., and Born, A. I. Expression of the histone H3 gene in benign, semi-malignant and malignant lesions of the head and neck: a reliable proliferation marker. Eur. J. Cancer, 29A: 1454-1461, 1993.
13. Chou, M. Y., Chang, A. L. C., McBride, J., Donoff, B., Gallagher, G. T., and Wong, D. T. W. A rapid method to determine proliferation patterns of normal and malignant tissues by H3 mRNA in situ hybridization. Am. J. Pathol., 136: 729-733, 1990.
14. Kotelnikov, V., Coon, J., Taylor, S., Hutchinson, J., Panje, W., Caldarelli, D., LaFollette, S., and Preisler, H. In vivo labeling with halogenated pyrimidines of squamous cell carcinomas and adjacent non-involved mucosa of head and neck region. Cell Prolif., 28: 497-509, 1995.
15. Reshatoff, M., Cass, L., and Spaulding, D. Simultaneous detection of mRNA targets and the nuclear antigens ER, p53, and Ki-67 by combined IHC and ISH on breast tumors. Lab. Invest., 72: 167A, 1995.
16. Preisler H. D., Kotelnikov, V., LaFollette, S., Taylor, S., Mundle, S., Wood, N., Coon, J., Hutchinson, J., Panje, W., Caldarelli, D., and Griem, K. Continued malignant cell proliferation in head and neck tumors during cytotoxic therapy. Clin. Cancer Res., 2: 1453-1460, 1996.